Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Genomic Valley Biotech Ltd

NSE: GVBL · BSE: 539206 · Pharmaceuticals & Biotechnology · 2 announcements

Share price: ₹27.65
Market cap: ₹8.45 Cr
Revenue (annual): ₹0.27 Cr
Net profit (annual): ₹0.03 Cr
P/E (TTM): 415.2×Sector 50.4×
Promoter holding: 46.06%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

14 Aug 2026 16:00 IST BSE

Financial Results

Genomic Valley Biotech Q1 FY27 Results: Net Profit ₹146,162 Cr, Down 40.7% YoY

Genomic Valley Biotech Ltd reported revenue from operations of ₹380,000 Cr (-57.8% YoY) and net profit of ₹146,162 Cr (-40.7% YoY) for Q1 FY27.

Key figure: Net profit ₹146,162 Cr · -40.7% YoY

Open full results → Read the filing ↗

29 May 2026 17:46 IST BSE

Financial Results

Genomic Valley Biotech Q4 FY26 Results: Net Loss of ₹81,745 Cr, Loss Narrows

Genomic Valley Biotech Ltd reported revenue from operations of ₹375,000 Cr (-85.8% YoY) and a net loss of ₹81,745 Cr for Q4 FY26.

Key figure: Net loss ₹81,745 Cr

Open full results → Read the filing ↗